
AGL
USDagilon health inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$3.990
Haut
$3.995
Bas
$3.785
Volume
0.01M
Fondamentaux de l'Entreprise
Capitalisation Boursière
1.6B
Industrie
Medical Care Facilities
Pays
United States
Statistiques de Trading
Volume Moyen
6.10M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 16 avr. 2025[AGL: agilon health inc. Common Stock]: Mixed Analyst Views, Recent Price Jump - What's Next?
Stock Symbol: AGL Generate Date: 2025-04-16 02:30:17
Alright, let's take a look at agilon health (AGL). This healthcare company has been making some moves, and analysts are all over the place with their opinions, which can be confusing if you're just trying to figure out what's going on. So, let's break it down simply.
Recent News Buzz - What's the Vibe?
The news is a bit of a mixed bag, honestly. We've got analysts from different firms weighing in, and they're not all singing the same tune.
- Some are getting more optimistic: Bernstein actually upgraded the stock to "Outperform" and bumped their price target way up to $8.50. That's a pretty strong positive signal. TD Cowen also raised their price target, though they're still just saying "Hold" for now.
- Others are a bit more cautious: Baird, for example, kept their "Neutral" rating and lowered their price target. This suggests they're not seeing huge upside right now.
What does this mean? Basically, Wall Street is a bit divided on AGL. Some think it's got more room to run, while others are playing it cool. The fact that Bernstein is so bullish is definitely something to notice, though. It's also worth noting that the company is going to be at a big healthcare conference soon and will be reporting earnings. These events can often move the stock price.
Price Check - What's the Stock Been Doing?
Looking at the price chart over the last month or so, it's been a bit of a rollercoaster, but with a recent big jump.
- Early March Slump: The stock was actually trending downwards for a while in early March, hitting lows around $2.80-$3.00.
- Then, a Turnaround: Starting mid-March, things started to pick up. The price climbed pretty steadily through March.
- Big Pop!: Then, BAM! On April 8th, the stock price skyrocketed from around $4 to over $5. It jumped on really heavy trading volume, meaning a lot of people were buying. Since then, it's been hanging around the $5.50-$5.75 range.
Where are we now? The stock is currently around $5.60 (previous close). That big jump on April 8th is hard to ignore. It suggests something shifted investor sentiment, maybe related to that Bernstein upgrade or just general market vibes.
AI Prediction in the Mix: Interestingly, the AI prediction model thinks the price is going to inch up a bit more over the next few days, but only by small percentages (around 1-3% per day). It's not predicting another huge jump right away.
Outlook & Ideas - What Could Happen Next?
Putting it all together, here's a possible way to look at AGL right now:
- Near-Term Lean: The recent price jump and the Bernstein upgrade suggest there might be some bullish momentum in the short term. The AI predictions, while modest, also point to continued upward movement.
- Potential 'Buy' Consideration? If you were thinking about getting into AGL, the current price area around $5.50 - $5.70 might be an interesting spot to consider. Why? Because it's right around where the stock has been consolidating after that big jump. It could be a sign of a new, higher base forming. However, and this is important, the stock has already moved up a lot recently, so some caution is definitely warranted.
- Entry Level Idea: Maybe watch for a slight dip towards the $5.50 level. If it holds around there, that could be a potential entry point. But again, no guarantees!
- Exit/Stop-Loss Thoughts:
- Profit Target: If Bernstein's $8.50 target is in the back of your mind, that's a potential longer-term profit area. For a shorter-term trade, maybe look closer to the other analyst targets around $6.00.
- Stop-Loss: To manage risk, a stop-loss could be placed below the recent lows, perhaps around $5.05. This is just below some recent price action and could help limit losses if the stock reverses.
Important Caveat: This is just based on the limited information we have here. The analyst opinions are mixed, and the AI prediction is just one model's view. The stock market is unpredictable, and AGL is no exception.
Company Context - Quick Background
Just a quick reminder: agilon health is in the business of providing healthcare services for seniors. They work with primary care doctors. The healthcare sector itself can be sensitive to news about regulations, costs, and overall economic conditions. Keep that in mind as you follow AGL.
In short: AGL has seen a recent price surge and has some positive analyst attention, but also some caution. It's a stock that's showing some potential, but like any investment, it comes with risks. Keep an eye on upcoming news and earnings reports to get a clearer picture.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Actualités Connexes
JMP Securities Reiterates Market Perform on Agilon Healthto Market Perform
JMP Securities analyst Constantine Davides reiterates Agilon Health from Market Perform to Market Perform.
Citigroup Upgrades Agilon Health to Buy, Raises Price Target to $5
Citigroup analyst Daniel Grosslight upgrades Agilon Health from Neutral to Buy and raises the price target from $3.25 to $5.
TD Cowen Maintains Hold on Agilon Health, Raises Price Target to $6
TD Cowen analyst Ryan Langston maintains Agilon Health with a Hold and raises the price target from $3.5 to $6.
Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5
Baird analyst Michael Halloran maintains Agilon Health with a Neutral and lowers the price target from $6 to $5.
Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $8.5
Bernstein analyst Amir Farahan upgrades Agilon Health from Market Perform to Outperform and raises the price target from $3.3 to $8.5.
Prédiction IABeta
Recommandation IA
Mis à jour le: 28 avr. 2025, 14:27
69.4% Confiance
Risque et Trading
Point d'Entrée
$3.90
Prise de Bénéfices
$3.96
Stop Loss
$3.49
Facteurs Clés
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.